Sitagliptin improves postprandial hyperglycemia by inhibiting glucagon secretion in Werner syndrome with diabetes

doi:10.2337/dc13-0709

Case Reports

. 2013 Aug;36(8):e119.

doi: 10.2337/dc13-0709.

Sitagliptin improves postprandial hyperglycemia by inhibiting glucagon secretion in Werner syndrome with diabetes

Kaneyuki Watanabe, Kazuki Kobayashi, Minoru Takemoto, Ryoichi Ishibashi, Masaya Yamaga, Harukiyo Kawamura, Masaki Fujimoto, Takahiro Ishikawa, Shunichiro Onishi, Emiko Okabe, Peng He, Koutaro Yokote

PMID: 23881973
PMCID: PMC3714499
DOI: 10.2337/dc13-0709

Case Reports

Sitagliptin improves postprandial hyperglycemia by inhibiting glucagon secretion in Werner syndrome with diabetes

Kaneyuki Watanabe et al. Diabetes Care. 2013 Aug.

. 2013 Aug;36(8):e119.

doi: 10.2337/dc13-0709.

Authors

Kaneyuki Watanabe, Kazuki Kobayashi, Minoru Takemoto, Ryoichi Ishibashi, Masaya Yamaga, Harukiyo Kawamura, Masaki Fujimoto, Takahiro Ishikawa, Shunichiro Onishi, Emiko Okabe, Peng He, Koutaro Yokote

PMID: 23881973
PMCID: PMC3714499
DOI: 10.2337/dc13-0709

No abstract available

PubMed Disclaimer

Cited by

Werner Syndrome-specific induced pluripotent stem cells: recovery of telomere function by reprogramming.
Shimamoto A, Yokote K, Tahara H. Shimamoto A, et al. Front Genet. 2015 Jan 29;6:10. doi: 10.3389/fgene.2015.00010. eCollection 2015. Front Genet. 2015. PMID: 25688260 Free PMC article. Review.
Factors Predicting Therapeutic Efficacy of Combination Treatment With Sitagliptin and Insulin in Type 2 Diabetic Patients: The ASSIST-K Study.
Ishikawa M, Takai M, Maeda H, Kanamori A, Kubota A, Amemiya H, Iizuka T, Iemitsu K, Iwasaki T, Uehara G, Umezawa S, Obana M, Kaneshige H, Kaneshiro M, Kawata T, Sasai N, Saito T, Takuma T, Takeda H, Tanaka K, Tsurui N, Nakajima S, Hoshino K, Honda S, Machimura H, Matoba K, Minagawa F, Minami N, Miyairi Y, Mokubo A, Motomiya T, Waseda M, Miyakawa M, Naka Y, Terauchi Y, Tanaka Y, Matsuba I. Ishikawa M, et al. J Clin Med Res. 2015 Aug;7(8):607-12. doi: 10.14740/jocmr2149w. Epub 2015 Jun 9. J Clin Med Res. 2015. PMID: 26124906 Free PMC article.
Comparative Study on Adding Pioglitazone or Sitagliptin to Patients with Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin.
Jameshorani M, Sayari S, Kiahashemi N, Motamed N. Jameshorani M, et al. Open Access Maced J Med Sci. 2017 Dec 12;5(7):955-962. doi: 10.3889/oamjms.2017.193. eCollection 2017 Dec 15. Open Access Maced J Med Sci. 2017. PMID: 29362626 Free PMC article.
Truncation of POC1A associated with short stature and extreme insulin resistance.
Chen JH, Segni M, Payne F, Huang-Doran I, Sleigh A, Adams C; UK10K Consortium; Savage DB, O'Rahilly S, Semple RK, Barroso I. Chen JH, et al. J Mol Endocrinol. 2015 Oct;55(2):147-58. doi: 10.1530/JME-15-0090. J Mol Endocrinol. 2015. PMID: 26336158 Free PMC article.

References

1. Epstein CJ, Martin GM, Schultz AL, Motulsky AG. Werner’s syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) 1966;45:177–221 - PubMed
1. Hattori S, Kasai M, Namatame T, Hattori Y, Kasai K. Pioglitazone treatment of insulin resistance in a patient with Werner’s syndrome. Diabetes Care 2004;27:3021–3022 - PubMed
1. Yokote K, Hara K, Mori S, Kadowaki T, Saito Y, Goto M. Dysadipocytokinemia in werner syndrome and its recovery by treatment with pioglitazone. Diabetes Care 2004;27:2562–2563 - PubMed
1. Yamada K, Ikegami H, Yoneda H, Miki T, Ogihara T. All patients with Werner’s syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes. Diabetes Care 1999;22:2094–2095 - PubMed
1. Kitamoto T, Takemoto M, Fujimoto M, et al. Sitagliptin successfully ameliorates glycemic control in Werner syndrome with diabetes. Diabetes Care 2012;35:e83. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Epstein CJ, Martin GM, Schultz AL, Motulsky AG. Werner’s syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) 1966;45:177–221 - PubMed

[2] Epstein CJ, Martin GM, Schultz AL, Motulsky AG. Werner’s syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) 1966;45:177–221 - PubMed

[3] Hattori S, Kasai M, Namatame T, Hattori Y, Kasai K. Pioglitazone treatment of insulin resistance in a patient with Werner’s syndrome. Diabetes Care 2004;27:3021–3022 - PubMed

[4] Hattori S, Kasai M, Namatame T, Hattori Y, Kasai K. Pioglitazone treatment of insulin resistance in a patient with Werner’s syndrome. Diabetes Care 2004;27:3021–3022 - PubMed

[5] Yokote K, Hara K, Mori S, Kadowaki T, Saito Y, Goto M. Dysadipocytokinemia in werner syndrome and its recovery by treatment with pioglitazone. Diabetes Care 2004;27:2562–2563 - PubMed

[6] Yokote K, Hara K, Mori S, Kadowaki T, Saito Y, Goto M. Dysadipocytokinemia in werner syndrome and its recovery by treatment with pioglitazone. Diabetes Care 2004;27:2562–2563 - PubMed

[7] Yamada K, Ikegami H, Yoneda H, Miki T, Ogihara T. All patients with Werner’s syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes. Diabetes Care 1999;22:2094–2095 - PubMed

[8] Yamada K, Ikegami H, Yoneda H, Miki T, Ogihara T. All patients with Werner’s syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes. Diabetes Care 1999;22:2094–2095 - PubMed

[9] Kitamoto T, Takemoto M, Fujimoto M, et al. Sitagliptin successfully ameliorates glycemic control in Werner syndrome with diabetes. Diabetes Care 2012;35:e83. - PMC - PubMed

[10] Kitamoto T, Takemoto M, Fujimoto M, et al. Sitagliptin successfully ameliorates glycemic control in Werner syndrome with diabetes. Diabetes Care 2012;35:e83. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Sitagliptin improves postprandial hyperglycemia by inhibiting glucagon secretion in Werner syndrome with diabetes

Sitagliptin improves postprandial hyperglycemia by inhibiting glucagon secretion in Werner syndrome with diabetes

Authors

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical